Occurrence of extended-spectrum beta-lactamases (ESBL) in Dutch hospitals

Infection

Volumn 27, Issue 6, 1999, Pages 348-354

  Stobberingh, E E ^a   Arends, J ^b   Hoogkamp Korstanje, J A A ^c   Goessens, W H F ^d   Visser, M R ^e   Buiting, A G M ^f   Debets Ossenkopp, Y J ^g   Van Ketel, R J ^g   Van Ogtrop, M L ^h   Sabbe, L J M ⁱ   Voorn, G P ^h   Winter, H L J ^j   Van Zeijl, J H ^k  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f Regional Laboratory of Public Health   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Oosterschelde Hospital   (Netherlands)

^j Public Health Service of Groningen   (Netherlands)

^k Public Health Service of Northern Friesland   (Netherlands)

more..

Author keywords

E. coli; Epidemiology; ESBL; Klebsiella

Indexed keywords

AMIKACIN; AMOXICILLIN; BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CLAVULANIC ACID; ENZYME VARIANT; GENTAMICIN; MEROPENEM; NETILMICIN; OFLOXACIN; PIPERACILLIN; TAZOBACTAM; TOBRAMYCIN;

ARTICLE; DEVICE; ENZYME SYNTHESIS; ESCHERICHIA COLI; HOSPITAL; HUMAN; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LABORATORY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NETHERLANDS; POLYMERASE CHAIN REACTION; PREVALENCE; SCREENING TEST;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; HUMANS; ISOELECTRIC FOCUSING; KLEBSIELLA; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NETHERLANDS; POLYMERASE CHAIN REACTION;

EID: 0032753380     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s150100050041     Document Type: Article

References (31)

1. Livermore DM: Betalactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-584.
2. Coudron PE, Moland ES, Sanders CC: Occurrence and detection of extended-spectrum betalactamases in members of the family Enterobacteriaceae at a veterans' medical center: seek and you may find. J Clin Microbiol 1997; 35: 2593-2597.
3. Kliebe C, Nies B, Meyer JF, Tolxdorff-Neuzling RM, Wiedemann B: Evolution of plasmid-encoded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 302-307.
4. Nicolas MH, Jarlier V, Honore N, Philippon A, Cole ST: Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33: 2096-2100.
5. Marchese A, Arlet G, Schito GC, Lagrange PH, Philippon A: Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis 1996; 15: 245-248.
6. Vatopoulos AC, Philippon A, Tzouvelekis LS, Komniou Z, Legakis NJ: Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26: 635-648.
7. Prodinger WM, Fille M, Bauernfeind A, Stemplinger I, Amann S, Pfausler B, Lassflorl C, Dierich MP: Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996; 34: 564-568.
8. Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, Rahal JJ, Bush K: SHV-7, a novel cefotaxime-hydrolysing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother 1995; 39: 899-905.
9. Mulgrave L, Attwood PV: Characterization of a SHV-5 related extended broad-spectrum beta-lactamase in Enterobacteriaceae from Western Australia. Pathology 1993; 25: 71-75.
10. Livermore DM, Yuan M: Antibiotic resistance and production of extended-spectrum betalactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409-424.
11. Matthew M, Harris AM, Marshall MJ, Ross GW: The use of analytical isoelectric focusing for detection and identification of betalactamases. J Gen Microbiol 1975; 88: 169-178.
12. Arlet G, Brami G, Décrè D, Flippo A, Gaillot O, Lagrange PH, Philippon A: Molecular characterisation by PCR-restriction fragment length polymorphism of TEM betalactamases. FEMS Microbiol Lett 1995; 134: 203-208.
13. Nüesch-Inderbinen MT, Hächler H, Kayser FH: Detection of genes coding for extended-spectrum SHV beta-lactamases in clinicalisolates by a molecular genetic method, and comparison with the E-test. Eur J Clin Microbiol Infect Dis 1996; 15: 398-402.
14. Ambler RP, Coulson AFW, Frère JM, Ghuysen JM, Joris B, Forsman M, Levesque RC, Tiraby G, Walley SG: A standard numbering scheme for the class a betalactamases. Biochem J 1991; 276: 269-272.
15. Vliegenhart JA, Ketelaar-van Gaalen PAG, van der Klundert JAM: Identification of three genes coding for aminoglycoside-modifying enzymes by means of the polymerase chain reaction. J Antimicrob Chemother 1990; 25: 759-765.
16. Jarlier V, Nicolas MH, Fournier G, Philippon A: Extended broad-spectrum betalactamases conferring transferable resistance to newer betalactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-878.
17. Ferraro MJ, Jacoby GA, Katsanis G: Improving the reliability of extended-spectrum beta-lactamase detection by the VITEK System. Abstract, 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, October 1992.
18. Sanders CC, Washington JA, Barry AL, Shubert C: Assessment of the VITEK ESBL test. Abstract, 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, October 1994.
19. Brown DFJ, Wattam A, Walpole E: Detection of extended-spectrum betalactamases (ESBL's) with the Etest ESBL strip. Abstracts, 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington DC 1995.
20. Harrel LJ, Thorpe JJ, McDonald LC, Reller LB: Analysis of suspected extended-spectrum beta-lactamase (ESBL)-producing Klebsiella spp. by the new E-test ESBL strip, double-disk diffusion test, and pulsed-field gel electrophoresis (PFGE). Abstracts, 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington DC 1995.
21. Vercauteren E, Descheemaeker P, Ieven M, Sanders CC, Goossens H: Comparison of screening methods for detection of extended-spectrum betalactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol 1997; 35: 2191-2197.
22. Cormican MG, Marshalla SA, Jones RN: Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen. J Clin Microbiol 1996; 34: 1880-1884.
23. Sirot D: Extended-spectrum plasmid-mediated beta-lactamases. J Antimicrob Chemother 1995; 36: 19-34.
24. Jacoby GA, Medeiros AA: More extended-spectrum betalactamases. Antimicrob Agents Chemother 1991; 35: 1697-1704.
25. Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC: Betalactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998; 42: 1350-1354.
26. Fernandez-Rodriquez A, Canton R, Perex-Diaz JC, Martinez-Beltran J, Picazo JJ, Baquero F: Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum betalactamases. Antimicrob Agents Chemother 1992; 36: 2536-2538.
27. Jacoby GA, Carreras I: Activities of betalactam antibiotics against Escherichia coli strains producing extended-spectrum betalactamases. Antimicrob Agents Chemother 1990; 34: 858-862.
28. Bush K: Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur J Clin Microbiol Infect Dis 1996; 15: 361-364.
29. Thomson KS, Prevan AM, Sanders CC: Novel plasmid-mediated betalactamases in Enterobacteriaceae: emerging problems for new betalactam antibiotics. Curr Clin Top Infect Dis 1996; 16: 151-163.
30. Jacoby GA, Han P: Detection of extended-spectrum betalactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996; 34: 908-911.
31. Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA: Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamase. J Clin Microbiol 1994; 32: 691-696.